Movement Disorders Unit, Sourasky Tel Aviv Medical Center
Welcome,         Profile    Billing    Logout  
 7 Trials 
9 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gurevich, Tanya
TEMPO-3, NCT04542499 / 2019-002951-40: Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations

Completed
3
507
Europe, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
01/24
02/24
TEMPO-1, NCT04201093 / 2019-002949-38: Fixed-Dose Trial in Early Parkinson's Disease (PD)

Active, not recruiting
3
522
Europe, Canada, US, RoW
Tavapadon, PF-06649751, CVL-751, Placebo
Cerevel Therapeutics, LLC
Parkinson Disease
09/24
10/24
NCT05126888: SCI-110 in the Treatment of Tourette Syndrome

Not yet recruiting
2
164
Europe, US, RoW
SCI-110, Placebo
SciSparc
Tourette Syndrome
08/25
12/25
LUMA, NCT05348785: A Study to Assess the Safety of BIIB122 Tablets and if it Can Slow the Worsening of Early-Stage Parkinson's Disease in Participants Between the Ages of 30 and 80

Recruiting
2
640
Europe, Canada, Japan, US, RoW
BIIB122, DNL151, BIIB122-Matching Placebo
Biogen, Denali Therapeutics Inc.
Parkinson Disease
12/25
12/25
NCT05822908 / 2022-001314-19: A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD

Recruiting
1/2
65
Europe, RoW
VO659
Vico Therapeutics B. V., VICO Therapeutics B.V.
Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 3, Huntington Disease
09/25
09/25
NCT05160558: A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3

Terminated
1
8
Europe, US, RoW
BIIB132, BIIB132-Matching Placebo
Biogen
Spinocerebellar Ataxia Type 3
07/23
07/23
NCT05795023: A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Recruiting
N/A
30
RoW
NeuraLight
NeuraLight
Parkinson Disease
02/24
03/24
ROPAD, NCT03866603: Rostock International Parkinson's Disease Study

Recruiting
N/A
25000
Europe, Canada, US, RoW
CENTOGENE GmbH Rostock
Parkinson´s Disease
12/25
12/25
Ezra, Adi
NCT05795023: A Longitudinal Evaluation of Oculometric Measures and Clinical Assessment Over Time in PD Patients

Recruiting
N/A
30
RoW
NeuraLight
NeuraLight
Parkinson Disease
02/24
03/24

Download Options